142 related articles for article (PubMed ID: 37392209)
1. Human metabolism and excretion kinetics of the surfactant 2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD) after oral and dermal administration.
Pluym N; Roegner N; Peschel O; Leibold E; Scherer G; Scherer M
Arch Toxicol; 2023 Sep; 97(9):2419-2428. PubMed ID: 37392209
[TBL] [Abstract][Full Text] [Related]
2. Determination of a specific metabolite for the non-ionic surfactant 2,4,7,9-Tetramethyl-5-decyne-4,7-diol (TMDD) by UPLC-MS/MS.
Roegner N; Pluym N; Peschel O; Leibold E; Kachhadia A; Scherer G; Scherer M
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123584. PubMed ID: 36640715
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and temporal variations of TMDD in the river Rhine, Germany.
Guedez AA; Frömmel S; Diehl P; Püttmann W
Environ Sci Pollut Res Int; 2010 Feb; 17(2):321-30. PubMed ID: 19526261
[TBL] [Abstract][Full Text] [Related]
4. Human metabolism and excretion kinetics of the fragrance 7-hydroxycitronellal after a single oral or dermal dosage.
Stoeckelhuber M; Krnac D; Pluym N; Scherer M; Peschel O; Leibold E; Scherer G
Int J Hyg Environ Health; 2018 Mar; 221(2):239-245. PubMed ID: 29108680
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics of bisphenol-S and its glucuronide in plasma and urine following oral and dermal exposure in volunteers for the interpretation of biomonitoring data.
Khmiri I; Côté J; Mantha M; Khemiri R; Lacroix M; Gely C; Toutain PL; Picard-Hagen N; Gayrard V; Bouchard M
Environ Int; 2020 May; 138():105644. PubMed ID: 32179324
[TBL] [Abstract][Full Text] [Related]
6. Toxicokinetics of a urinary metabolite of tebuconazole following controlled oral and dermal administration in human volunteers.
Oerlemans A; Verscheijden LFM; Mol JGJ; Vermeulen RCH; Westerhout J; Roeleveld N; Russel FGM; Scheepers PTJ
Arch Toxicol; 2019 Sep; 93(9):2545-2553. PubMed ID: 31359083
[TBL] [Abstract][Full Text] [Related]
7. Human metabolism and urinary excretion kinetics of the UV filter Uvinul A plus® after a single oral or dermal dosage.
Stoeckelhuber M; Scherer M; Peschel O; Leibold E; Bracher F; Scherer G; Pluym N
Int J Hyg Environ Health; 2020 Jun; 227():113509. PubMed ID: 32174481
[TBL] [Abstract][Full Text] [Related]
8. Development of a urinary biomarker for exposure to the organophosphate propetamphos: data from an oral and dermal human volunteer study.
Garfitt SJ; Jones K; Mason HJ; Cocker J
Biomarkers; 2002; 7(2):113-22. PubMed ID: 12101631
[TBL] [Abstract][Full Text] [Related]
9. Human Metabolism and Urinary Excretion Kinetics of Nonylphenol in Three Volunteers after a Single Oral Dose.
Ringbeck B; Belov VN; Schmidtkunz C; Küpper K; Gries W; Weiss T; Brüning T; Hayen H; Bury D; Leng G; Koch HM
Chem Res Toxicol; 2021 Nov; 34(11):2392-2403. PubMed ID: 34735116
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation and toxicokinetics of 2-phenoxyethanol after oral exposure in humans: a volunteer study.
Eckert E; Jäger T; Hiller J; Leibold E; Bader M; Göen T
Arch Toxicol; 2024 Jun; 98(6):1771-1780. PubMed ID: 38668861
[TBL] [Abstract][Full Text] [Related]
11. Human metabolism and urinary excretion kinetics of di-n-butyl adipate (DnBA) after oral and dermal administration in three volunteers.
Ringbeck B; Bury D; Gotthardt A; Hayen H; Otter R; Weiss T; Brüning T; Koch HM
Toxicol Lett; 2021 Jun; 343():11-20. PubMed ID: 33640488
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of Exposure to Pyrimethanil After Controlled Human Experiments.
Faniband M; Ekman E; Littorin M; Maxe M; Larsson E; Lindh CH
J Anal Toxicol; 2019 May; 43(4):277-283. PubMed ID: 30462228
[TBL] [Abstract][Full Text] [Related]
13. Human metabolism and excretion kinetics of the fragrance lysmeral after a single oral dosage.
Scherer M; Koch HM; Schütze A; Pluym N; Krnac D; Gilch G; Leibold E; Scherer G
Int J Hyg Environ Health; 2017 Mar; 220(2 Pt A):123-129. PubMed ID: 27633268
[TBL] [Abstract][Full Text] [Related]
14. R-Limonene metabolism in humans and metabolite kinetics after oral administration.
Schmidt L; Göen T
Arch Toxicol; 2017 Mar; 91(3):1175-1185. PubMed ID: 27325307
[TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
16. Human metabolism and kinetics of the UV absorber 2-(2H-benzotriazol-2-yl)-4,6-di-tert-pentylphenol (UV 328) after oral administration.
Denghel H; Hiller J; Leibold E; Göen T
Arch Toxicol; 2021 Aug; 95(8):2677-2690. PubMed ID: 34180011
[TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics of urinary 2-ethylhexyl salicylate and its metabolite 2-ethyl-hydroxyhexyl salicylate in humans after simulating real-life dermal sunscreen exposure.
Hiller J; Klotz K; Meyer S; Uter W; Hof K; Greiner A; Göen T; Drexler H
Arch Toxicol; 2019 Sep; 93(9):2565-2574. PubMed ID: 31435713
[TBL] [Abstract][Full Text] [Related]
18. Simulation of urinary excretion of 1-hydroxypyrene in various scenarios of exposure to polycyclic aromatic hydrocarbons with a generic, cross-chemical predictive PBTK-model.
Jongeneelen F; ten Berge W
Int Arch Occup Environ Health; 2012 Aug; 85(6):689-702. PubMed ID: 22038087
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetic modeling of captan fungicide and its tetrahydrophthalimide biomarker of exposure in humans.
Heredia-Ortiz R; Bouchard M
Toxicol Lett; 2012 Aug; 213(1):27-34. PubMed ID: 21979173
[TBL] [Abstract][Full Text] [Related]
20. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
